Back to today’s briefing

Story perspectives

Biotech Boom: Market Projected to Hit $4.61 Trillion by 2034

2/1/2025

50 10

Summary

Story summary

The biotechnology sector is on an exhilarating upward trajectory, fueled by groundbreaking therapies and artificial intelligence. Vertex Pharmaceuticals, Amgen, and Gilead Sciences stand out as promising investment opportunities, with Vertex's revenue soaring by 11.6%, Amgen's by an impressive 23.2%, and Gilead's by 7%. By 2034, the global biotech market is expected to skyrocket to $4.61 trillion, growing at a remarkable 11.5% annually.

1 of 1

Story summary

The biotechnology sector is on an exhilarating upward trajectory, fueled by groundbreaking therapies and artificial intelligence. Vertex Pharmaceuticals, Amgen, and Gilead Sciences stand out as promising investment opportunities, with Vertex's revenue soaring by 11.6%, Amgen's by an impressive 23.2%, and Gilead's by 7%. By 2034, the global biotech market is expected to skyrocket to $4.61 trillion, growing at a remarkable 11.5% annually.